NGM Bio Announces Closing of Tender Offer
SAN FRANCISCO, April 05, 2024 -- NGM Biopharmaceuticals, Inc. , a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that Atlas...
Stay updated with breaking news from Column Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN FRANCISCO, April 05, 2024 -- NGM Biopharmaceuticals, Inc. , a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that Atlas...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of NGM Biopharmaceuticals, Inc. to affiliates of The...
13.03.2024 - Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NGM Biopharmaceuticals, Inc. (NasdaqGS: NGM) to affiliates of The Column Group, LP. Under the ...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!